# Bumetanide vs. Furosemide in Cirrhosis

> **NCT06941415** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Stacy Johnson** · enrollment: 500 (estimated)

## Conditions studied

- Cirrhosis

## Interventions

- **DRUG:** Bumetanide
- **DRUG:** Furosemide

## Key facts

- **NCT ID:** NCT06941415
- **Lead sponsor:** Stacy Johnson
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-18
- **Primary completion:** 2029-03-01
- **Final completion:** 2029-03-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06941415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06941415, "Bumetanide vs. Furosemide in Cirrhosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06941415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*